|
ES2427166T3
(es)
|
2003-06-23 |
2013-10-29 |
Ono Pharmaceutical Co., Ltd. |
Compuesto heterocíclico tricíclico novedoso
|
|
SG184755A1
(en)
|
2004-03-15 |
2012-10-30 |
Ptc Therapeutics Inc |
Carboline derivatives useful in the inhibition of angiogenesis
|
|
US8076352B2
(en)
|
2004-03-15 |
2011-12-13 |
Ptc Therapeutics, Inc. |
Administration of carboline derivatives useful in the treatment of cancer and other diseases
|
|
US7767689B2
(en)
*
|
2004-03-15 |
2010-08-03 |
Ptc Therapeutics, Inc. |
Carboline derivatives useful in the treatment of cancer
|
|
US8076353B2
(en)
|
2004-03-15 |
2011-12-13 |
Ptc Therapeutics, Inc. |
Inhibition of VEGF translation
|
|
US7964726B2
(en)
|
2004-12-22 |
2011-06-21 |
Ono Pharmaceutical Co., Ltd. |
Tricyclic compound and use thereof
|
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
JP2010505962A
(ja)
|
2006-10-09 |
2010-02-25 |
武田薬品工業株式会社 |
キナーゼ阻害剤
|
|
WO2008103470A2
(en)
|
2007-02-21 |
2008-08-28 |
Trustees Of Columbia University In The City Of New York |
Oncogenic-ras-signal dependent lethal compounds
|
|
US11202775B2
(en)
|
2007-09-25 |
2021-12-21 |
Minerva Biotechnologies Corporation |
Methods for treatment of cancer
|
|
WO2009042815A1
(en)
*
|
2007-09-25 |
2009-04-02 |
Minerva Biotechnologies Corp. |
Methods for treatment of cancer
|
|
EP2050747A1
(en)
*
|
2007-10-12 |
2009-04-22 |
BioAlliance Pharma |
Dimers of harmol or of its derivatives and uses thereof
|
|
KR101614723B1
(ko)
|
2008-01-11 |
2016-04-22 |
알바니 몰레큘라 리써치, 인크. |
Ｍｃｈ 길항물질로서 (1-아지논)-치환된 피리도인돌
|
|
CN101591348B
(zh)
*
|
2008-05-30 |
2011-07-27 |
首都医科大学 |
四氢咔啉酰氨基酸苄酯及其制备方法和应用
|
|
CN101597289B
(zh)
*
|
2008-06-02 |
2011-09-21 |
首都医科大学 |
2-色氨酰-β-四氢咔啉-3-甲酰基氨基酸苄酯及其制备方法和应用
|
|
WO2010138652A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating kaposi sarcoma
|
|
MX2011012517A
(es)
|
2009-05-27 |
2012-01-27 |
Ptc Therapeutics Inc |
Procesos para la preparacion de tetrahidro beta - carbolina sustituidas.
|
|
CA3184380A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating cancer and non-neoplastic conditions
|
|
US8703726B2
(en)
|
2009-05-27 |
2014-04-22 |
Ptc Therapeutics, Inc. |
Methods for treating prostate conditions
|
|
US8629158B2
(en)
*
|
2009-07-01 |
2014-01-14 |
Albany Molecular Research, Inc. |
Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
|
|
WO2011003021A1
(en)
*
|
2009-07-01 |
2011-01-06 |
Albany Molecular Research, Inc. |
Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
|
|
JP2012532144A
(ja)
|
2009-07-01 |
2012-12-13 |
アルバニー モレキュラー リサーチ， インコーポレイテッド |
アジノン置換アゼピノ［ｂ］インドールおよびピリド−ピロロ−アゼピンｍｃｈ−１拮抗薬、ならびにその作製方法および使用
|
|
US8618299B2
(en)
*
|
2009-07-01 |
2013-12-31 |
Albany Molecular Research, Inc. |
Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof
|
|
FR2953839A1
(fr)
*
|
2009-12-14 |
2011-06-17 |
Sanofi Aventis |
Nouveaux derives d'(heterocycle-piperidine condensee)-(piperazinyl)-1alcanone ou d'(heterocycle-pyrrolidine condensee)-(piperazinyl)-1alcanone et leur utilisation comme inhibiteurs de p75
|
|
SG186826A1
(en)
|
2010-07-06 |
2013-02-28 |
Ono Pharmaceutical Co |
Tetrahydrocarboline derivative
|
|
US8993765B2
(en)
|
2010-12-21 |
2015-03-31 |
Albany Molecular Research, Inc. |
Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
|
|
US8697700B2
(en)
|
2010-12-21 |
2014-04-15 |
Albany Molecular Research, Inc. |
Piperazinone-substituted tetrahydro-carboline MCH-1 antagonists, methods of making, and uses thereof
|
|
ES2587856T3
(es)
|
2011-03-18 |
2016-10-27 |
Ono Pharmaceutical Co., Ltd. |
Derivado de tetrahidrocarbolina
|
|
DK2802328T3
(en)
*
|
2012-01-09 |
2018-06-14 |
X Chem Inc |
TRYPTOLIN DERIVATIVES WITH KINASE INHIBITIVE ACTIVITY AND APPLICATIONS THEREOF
|
|
CN103087062B
(zh)
*
|
2013-01-19 |
2015-06-03 |
安徽师范大学 |
N-磺酰基取代-β-四氢咔啉衍生物的制备方法
|
|
BR112015029455A8
(pt)
*
|
2013-05-28 |
2020-03-17 |
Astrazeneca Ab |
compostos químicos, uso, métodos e composições para prevenção ou tratamento de câncer
|
|
CN108513537A
(zh)
*
|
2015-09-23 |
2018-09-07 |
米纳瓦生物技术公司 |
筛选分化干细胞的试剂的方法
|
|
JP2019001715A
(ja)
*
|
2015-10-30 |
2019-01-10 |
協和発酵キリン株式会社 |
三環性化合物
|
|
US10519148B2
(en)
*
|
2015-11-12 |
2019-12-31 |
Zhejiang Hisun Pharmaceutical Co., Ltd. |
Acrylic acid derivative, preparation method and use in medicine thereof
|
|
CN106967063B
(zh)
*
|
2017-03-21 |
2019-01-11 |
浙江大学 |
1-三氟甲基-1,2,3,4-四氢-β-咔啉衍生物及其制备方法
|
|
KR20200035292A
(ko)
|
2017-08-01 |
2020-04-02 |
피티씨 테라퓨틱스, 인크. |
혈액 암 치료에 사용하기 위한 dhodh 억제제
|
|
WO2020072675A1
(en)
|
2018-10-02 |
2020-04-09 |
Northwestern University |
Beta-carbolines as positive allosteric modulators of the human serotonin receptor 2c (5-ht2c)
|
|
CN110791389B
(zh)
*
|
2019-09-30 |
2021-06-01 |
义乌欧风汽车用品有限公司 |
一种除胶剂及其制备方法和应用
|
|
CR20240264A
(es)
*
|
2021-12-31 |
2024-09-03 |
Ptc Therapeutics Inc |
Compuestos de carbolina y uso de los mismos
|
|
EP4615838A1
(en)
*
|
2022-11-07 |
2025-09-17 |
Merck Patent GmbH |
Substituted bi-and tricyclic hset inhibitors
|